Search - tctmd.com

Displaying 41 - 60 of 75

Sort: Relevancy | Date

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

February 07, 2018

Next-Generation Large-Bore Closure Devices Arrive

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

February 05, 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

News Conference News ISC 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

January 25, 2018

Updated Stroke Guidelines Incorporate Just-Published Evidence Supporting Late-Window Thrombectomy

News Conference News ISC 2018

Updated Stroke Guidelines Incorporate Just-Published Evidence Supporting Late-Window Thrombectomy

January 24, 2018

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

November 14, 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

September 15, 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

August 27, 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

News Conference News ISET 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

February 13, 2017

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

November 02, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

November 01, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

September 22, 2016

News Conference News VIVA 2016

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

September 21, 2016

News Conference News ESC 2016

Screening for and Treating Asymptomatic Extracoronary Disease No Help in High-risk CAD

August 29, 2016

News Conference News ISC 2016

Thrombectomy for Acute Stroke Works Across Subgroups, but Best When Done Early

February 22, 2016

News Conference News ISC 2016

PISTE Trial Adds to Mounting Evidence Supporting Endovascular Therapy in Acute Stroke

February 17, 2016

News Conference News ISC 2016

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

February 17, 2016

News Conference News ISET 2016

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Michael O'Riordan

February 08, 2016

News Conference News ISET 2016

To Check or Not to Check? Carotid Screening Should be Limited to Highly Selected Patients, Say Experts

Michael O'Riordan

February 07, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.